EMEA-000510-PIP02-10-M02 - paediatric investigation plan

tazarotene

Key facts

• Active substance:
  tazarotene
• Therapeutic area:
  Dermatology
• Decision number:
  P/0250/2012
• PIP number:
  EMEA-000510-PIP02-10-M02
• Pharmaceutical form(s):
  Cream
• Condition(s) / indication(s):
  Treatment of lamellar ichthyosis
• Route(s) of administration:
  Cutaneous use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  24/10/2012
• Compliance check done:
  No

Decision

P/0250/2012: EMA decision of 24 October 2012 on the acceptance of a modification of an agreed paediatric investigation plan for tazarotene (EMEA-000510-PIP02-10-M02)

Adopted Reference Number: EMA/666117/2012